CS logo
small CS logo
Acclaim Dermatology, PLLC

Sugar Land, Texas, United States
Dermatologist in Sugar Land, Texas
17510 W Grand Pkwy S #385, Sugar Land, TX 77479

About Acclaim Dermatology, PLLC


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Acclaim Dermatology, PLLC


During the past decade, Acclaim Dermatology, PLLC conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Acclaim Dermatology, PLLC" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "RAPT Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Acclaim Dermatology, PLLC" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Acclaim Dermatology, PLLC


According to Clinical.Site data, the most researched conditions in "Acclaim Dermatology, PLLC" are "Atopic Dermatitis" (5 trials), "Psoriasis" (2 trials) and "Plaque Psoriasis" (1 trials). Many other conditions were trialed in "Acclaim Dermatology, PLLC" in a lesser frequency.

Clinical Trials Intervention Types at Acclaim Dermatology, PLLC


Most popular intervention types in "Acclaim Dermatology, PLLC" are "Drug" (6 trials), "Biological" (2 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "BMS-986165" (2 trials), "Lebrikizumab" (2 trials), "ABP 654" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Acclaim Dermatology, PLLC


The vast majority of trials in "Acclaim Dermatology, PLLC" are 8 trials for "All" genders.

Clinical Trials Status at Acclaim Dermatology, PLLC


Currently, there are NaN active trials in "Acclaim Dermatology, PLLC". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Acclaim Dermatology, PLLC, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Acclaim Dermatology, PLLC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".